These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6431599

  • 1. [Alterations of the state of consciousness induced by valproic acid: 6 case reports].
    Campostrini R, Paganini M, Boncinelli L, Zaccara G, Arnetoli G, Zappoli R.
    Riv Patol Nerv Ment; 1983; 104(1):23-34. PubMed ID: 6431599
    [Abstract] [Full Text] [Related]

  • 2. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT, Burcet J, Ramió L, Ustrell X, Silva Y, Molins A.
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [Abstract] [Full Text] [Related]

  • 3. [Encephalopathies caused by valproate].
    Göbel R, Görtzen A, Bräunig P.
    Fortschr Neurol Psychiatr; 1999 Jan; 67(1):7-11. PubMed ID: 10065384
    [Abstract] [Full Text] [Related]

  • 4. Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of 8 cases.
    Zaccara G, Paganini M, Campostrini R, Arnetoli G, Zappoli R, Moroni F.
    Eur Neurol; 1984 Jan; 23(2):104-12. PubMed ID: 6426961
    [Abstract] [Full Text] [Related]

  • 5. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
    Chopra A, Kolla BP, Mansukhani MP, Netzel P, Frye MA.
    Gen Hosp Psychiatry; 2012 Jan; 34(3):290-8. PubMed ID: 22305367
    [Abstract] [Full Text] [Related]

  • 6. [Role of hyperammonemia in stuporous states induced by sodium valproate].
    Warter JM, Marescaux C, Rumbach L, Micheletti G, Chabrier G, Koehl C, Imler M, Collard M.
    Rev Neurol (Paris); 1983 Jan; 139(12):753-7. PubMed ID: 6420866
    [Abstract] [Full Text] [Related]

  • 7. Encephalopathy and myoclonus triggered by valproic acid.
    Reif A, Leonhard C, Mössner R, Lesch KP, Fallgatter AJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1061-3. PubMed ID: 15380868
    [Abstract] [Full Text] [Related]

  • 8. [A case report of valproate encephalopathy].
    Miyamoto T, Miyamoto M, Hirata K, Katayama S.
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [Abstract] [Full Text] [Related]

  • 9. Valproate-induced encephalopathy.
    Chen WT, Yen DJ, Yu HY, Liao KK.
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Aug; 64(8):474-8. PubMed ID: 11720147
    [Abstract] [Full Text] [Related]

  • 10. Valproate-induced hyperammonemia.
    Batshaw ML, Brusilow SW.
    Ann Neurol; 1982 Mar; 11(3):319-21. PubMed ID: 6807193
    [Abstract] [Full Text] [Related]

  • 11. The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?
    Chicharro AV, de Marinis AJ, Kanner AM.
    Epilepsy Behav; 2007 Nov; 11(3):361-6. PubMed ID: 17845866
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ, Lluch-Fernández MD, Vaquero-Abellán M, Marchante-Serrano C, Jiménez C.
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [Abstract] [Full Text] [Related]

  • 13. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J, Franks R, Roane D, Bayard M.
    J Am Board Fam Med; 2007 Jul; 20(5):499-502. PubMed ID: 17823470
    [Abstract] [Full Text] [Related]

  • 14. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
    Cheng M, Tang X, Wen S, Yue J, Wang H.
    Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
    [Abstract] [Full Text] [Related]

  • 15. [Encephalopathy with asterixis induced by sodium valproate. Role of hyperammonemia without hepatic insufficiency].
    Gastaut JL, Mege JL.
    Presse Med; 1985 Feb 16; 14(7):431. PubMed ID: 3157141
    [No Abstract] [Full Text] [Related]

  • 16. Topiramate increases the risk of valproic acid-induced encephalopathy.
    Noh Y, Kim DW, Chu K, Lee ST, Jung KH, Moon HJ, Lee SK.
    Epilepsia; 2013 Jan 16; 54(1):e1-4. PubMed ID: 22691153
    [Abstract] [Full Text] [Related]

  • 17. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA, Abdella MM.
    Epilepsy Res; 2009 Sep 16; 86(1):32-41. PubMed ID: 19446440
    [Abstract] [Full Text] [Related]

  • 18. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
    Meinardi MC, van den Berg GB, Groenhuijzen A, Driessen JT, Maas HA, Wolfhagen FH.
    Ned Tijdschr Geneeskd; 2008 Feb 02; 152(5):278-82. PubMed ID: 18333544
    [Abstract] [Full Text] [Related]

  • 19. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK, Gazioğlu S.
    Acta Neurol Scand; 2007 Aug 02; 116(2):128-32. PubMed ID: 17661800
    [Abstract] [Full Text] [Related]

  • 20. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T, Buesing D, Longin E, Bendl C, Wenzel D, Scheid B, Goetze G, Macke A, Lippert G, Klostermann W, Mayer G, Augspach-Hofmann R, Fitzek S, Haensch CA, Reuland M, Koenig SA.
    Seizure; 2006 Sep 02; 15(6):443-8. PubMed ID: 16787750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.